What is the ticker symbol for Silo Pharma?

Silo Pharma trades under the ticker SILO on NASDAQ.

What sector does Silo Pharma operate in?

Silo Pharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze SILO in a portfolio?

PortView shows SILO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Silo Pharma (SILO) Stock Analysis

NASDAQHealthcareBiotechnology

$2.50+2.46%

1-year price historyRange $2.44 – $12.23

52-week range$2.50

$2.43$15.15

What Silo Pharma does

Silo Pharma Inc. operates as a developmental-stage biopharmaceutical firm dedicated to creating treatments for a variety of underserviced medical conditions. These include stress-related psychiatric disorders, persistent pain syndromes, and diseases impacting the central nervous system (CNS). The company's approach combines both traditional and psychedelic therapies, with a strong emphasis on innovative formulations and advanced drug delivery systems. Leading its pipeline is SPC-15, an intranasal treatment engineered to address post-traumatic stress disorder (PTSD) and anxiety disorders stemming from stress. Another key development is SP-26, a time-release, ketamine-loaded implant designed to provide relief for fibromyalgia and chronic pain. Furthermore, Silo Pharma is advancing two preclinical programs: SPC-14, an intranasal compound targeting Alzheimer's disease, and SPU-16, a CNS-homing peptide intended for the management of multiple sclerosis (MS). The company's research and development efforts frequently involve collaborations with prominent academic institutions such as Columbia University and the University of Maryland, Baltimore. Founded in 2010, the company adopted its current name, Silo Pharma, Inc., in September 2020, having previously operated as Uppercut Brands, Inc. Silo Pharma is headquartered in Sarasota, Florida.

Key metrics

Market cap

$2.82M

P/E (TTM)

-0.81

EPS (TTM)

$-3.10

Beta

0.80

Dividend yield

0.00%

Revenue / share

$0.05

50-day avg

$4.43

200-day avg

$5.50

52-week high

$15.15

52-week low

$2.43

CEO

Eric Weisblum

ETFs linked to SILO

Broad-market and Healthcare sector ETFs an investor holding Silo Pharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how SILO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SILO in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Silo Pharma?: Silo Pharma trades under the ticker SILO on NASDAQ.
Which exchange is SILO listed on?: SILO is listed on NASDAQ.
What sector does Silo Pharma operate in?: Silo Pharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze SILO in a portfolio?: PortView shows SILO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.